Share Market Live: SGX Nifty Hints At Losses; Paytm, Sapphire Foods, Vedanta, Zomato In Focus

• Edelweiss has 2.1 million shares change hands in a block trade

• Details of buyers and sellers are not immediately known

Source: Bloomberg

• Gokaldas Exports rated 'new buy' at JM Financial; price target: Rs 400

• Paytm rated 'underperform' at Macquarie, price target: Rs 1,200

Source: Bloomberg

Cadila Healthcare Ltd. received final approval from the U.S. FDA to market Nelarabine injection 250 mg/50 ml in the U.S.

• Zydus Pharmaceuticals USA Inc was granted a competitive generic therapy (CGT) designation for Nelarabine injection, 250 mg/50 ml, single-dose vial.

• Zydus is the first approved applicant for Nelarabine injection. The injection had annual sales of approximately $34.5 million in the U.S., according to IQVIA data.

• Nelarabine injection is a chemotherapy drug used to treat certain types of leukemia and lymphoma and is used to stop the growth of cancer cells.

• Escorts: To Meet Thursday for Fundraising Options

• Infosys: MSG Sports, MSG Entertainment in Marketing PactWith Infosys

• Jindal Drilling: Has Acquired an Offshore Jack-up Rig ‘Jindal Supreme’ from Venus Drilling for $16.75M

• Lupin: Gilead, J&J Sue Lupin, MSN Labs to Block Copies of Symtuza Drug

• One 97 Communications, Sapphire Foods: To Start Trading on BSE/NSE after an IPO

• Seacoast Shipping Services: To Consider Stock Split

• Vedanta: To Separately List Aluminum, Iron, Oil Businesses

• Zomato: May Invest $500M in Grofers: ET

• Tata Sons starts work on merging AirAsia India and Air India Express, Economic Times Reports, citing unidentified executives close to the development.

• Tata Sons plans to set up a single aviation holding company that will be an umbrella for all its airline businesses.

• Tata Sons did not respond to queries; AirAsia India spokesperson declined to comment: ET